Holen Sie sich die Stockscreener-App
9.20
0.11%
-0.01
Vorhandelsmarkt:
9.21
0.01
+0.11%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$9.21
Offen:
$9.22
24-Stunden-Volumen:
4.14M
Relative Volume:
0.92
Marktkapitalisierung:
$1.51B
Einnahmen:
$596.34M
Nettoeinkommen (Verlust:
$-87.84M
KGV:
-15.40
EPS:
-0.5975
Netto-Cashflow:
$-97.62M
1W Leistung:
+6.11%
1M Leistung:
+1.55%
6M Leistung:
+40.67%
1J Leistung:
+30.87%
1-Tages-Spanne:
$8.95
$9.595
1-Wochen-Bereich:
$8.45
$9.595
52-Wochen-Spanne:
$6.13
$11.97
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
21 FIRSTFIELD RD, GAITHERSBURG, MD
Compare NVAX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
9.20 | 1.51B | 596.34M | -87.84M | -97.62M | -0.5975 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-20 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Eingeleitet | Citigroup | Sell |
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - Stocktwits
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance Australia
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Novavax Price Target Maintained With a $19.00/Share by BTIG - Moomoo
NVAX News | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits
Novavax set for a seventh straight decline - MSN
Novavax Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
Novavax rises after six sessions of decline - MSN
Novavax Pivots To Matrix M Licensing As Sanofi Takes Europe - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax (NVAX) Shares Decline Amid Transition to Royalty Model - GuruFocus
(NVAX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - Stocktwits
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Novavax (NVAX) up 10.4% since last earnings report: Can it continue? - MSN
Novavax, Inc. (NVAX) is attracting investor attention: Here is what you should know - MSN
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
NOVAVAX INC (NVAX) Stock Chart - ChartMill
NVAX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Novavax Q1 2026 slides: partnership revenue surges amid strategic shift - Investing.com
Earnings call transcript: Novavax Q1 2026 beats forecasts, stock surges - Investing.com
Novavax Inc stock (US6707721049): Q1 2026 results and valuation metrics in focus - AD HOC NEWS
Novavax, Inc. Trade Ideas — BSESOF:NVV1 - TradingView
Novavax (NVAX) Up 10.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Novavax beats first-quarter revenue estimates on strength in vaccine deals - marketscreener.com
Novo Nordisk opens Czech facility for obesity drugs - marketscreener.com
Novavax rises after strong Q1 beat driven by Pfizer deal - MSN
NVAX Technical Analysis | Trend, Signals & Chart Patterns | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. (NVAX) Investors of Filing Deadline in Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - TMX Newsfile
Novavax to Participate in 2026 Jefferies Global Healthcare Confe - GuruFocus
Novavax to Participate in 2026 Jefferies Global Healthcare Conference - PR Newswire
Novavax Inc stock (US6707721049): Analyst consensus points to hold as NVAX trades near 11 USD - AD HOC NEWS
Novavax fireside chat at 2026 Jefferies Global Healthcare Conference - Stock Titan
Novavax Stock Soars 13.57%, Hits Intraday High of $10.52 - Markets Mojo
Novavax: The Pivot To A Royalty Model Is Working, But It's Still A Hold (NASDAQ:NVAX) - Seeking Alpha
Liquidity Mapping Around (NVAX) Price Events - Stock Traders Daily
Novavax Inc stock (US6707721049): shares trade around USD 10 after recent volatility and licensing f - AD HOC NEWS
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
FDA advisers recommend COVID vaccines be updated to target current dominant variant - Reuters
Novavax Inc stock (US66987V1098): NVAX trades at $11.09 on Nasdaq - AD HOC NEWS
R. Draghia Akli sells 30,000 NVAX shares (NASDAQ: NVAX) - Stock Titan
Why Novavax (NVAX) Stock Is Trading Up Today - Yahoo Finance
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):